# Focusight

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/focusight

- Industry: Healthcare Specialists
- Headquarters: Suzhou, China
- Latest round: Series A (Dec 16, 2025)
- Investors on record: 2

## About

Based in Suzhou, China and founded in 2022, Suzhou Focusight Medical Technology Co., Ltd., doing business as Focusight, is a provider of eye disease treatment and prevention services, providing comprehensive solutions for the treatment and prevention of common eye diseases. The company has established industry-university-research cooperation with Fudan University Eye, Ear, Nose and Throat Hospital and Sun Yat-sen University Eye Hospital. It has a subsidiary in Hangzhou, China that focuses on the development of ophthalmic medical devices. In October 2024, its therapeutic product designed for children with amblyopia obtained the Class II medical device product registration certificate issued by the Zhejiang Provincial Food and Drug Administration. 

In November 2024, Focusight closed pre-series A funding. In December 2025, the company closed series A funding from new investor Fong Capital Partners.

Focusight provides overall solutions for the treatment, prevention, and control of eye diseases. The company's products have covered the needs of amblyopia, dry eye, and end-of-eye patients. It has jointly developed a vision training method based on XR technology. The company generates revenue by developing and providing products for patients with amblyopia, myopia, dry eyes and end-of-eye disease.

The angel financing will accelerate the company's technology development and market expansion.

## Funding rounds

- Series A, Dec 16, 2025 — Fong Capital Partners
- Angel, Mar 16, 2023 — Marathon Venture Partners

## Investors

- Marathon Venture Partners (https://capitalatlas.ai/funds/marathon-venture-partners) — Angel
- Fong Capital Partners (https://capitalatlas.ai/funds/fong-capital-partners) — Series A